You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

ADVM-022-07

Showing 1 - 25 of 1,568
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Long-term Study of ADVM-022 in Neovascular (Wet) AMD [OPTIC-EXT]

Enrolling by invitation
  • Wet Age-related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Bakersfield, California
  • +8 more
Dec 23, 2021

Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)

Enrolling by invitation
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • ADVM-022
  • Beverly Hills, California
  • +6 more
Nov 4, 2022

Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Recruiting
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Phoenix, Arizona
  • +4 more
Sep 8, 2022

Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in United States (ADVM-022)

Active, not recruiting
  • Wet Age-related Macular Degeneration
  • Neovascular Age-related Macular Degeneration
  • ADVM-022
  • Bakersfield, California
  • +10 more
Mar 21, 2022

Diabetic Macular Edema, Diabetic Retinopathy Trial in Puerto Rico, United States (6E11 vg/eye of ADVM-022, 2E11 vg/eye of

Active, not recruiting
  • Diabetic Macular Edema
  • Diabetic Retinopathy
  • 6E11 vg/eye of ADVM-022
  • +2 more
  • Phoenix, Arizona
  • +13 more
Jan 10, 2022

Cancer, Relapsed/Refractory Large B-cell Lymphoma (LBCL) Trial (Fludarabine (30 mg/m^2), Cyclophosphamide (500 mg/m^2), CRG-022

Not yet recruiting
  • Cancer
  • Relapsed/Refractory Large B-cell Lymphoma (LBCL)
  • Fludarabine (30 mg/m^2)
  • +2 more
  • (no location specified)
Jul 25, 2023

Tumors Trial in Spain, United States (TSR-022, Nivolumab, TSR-042)

Recruiting
  • Neoplasms
  • Goodyear, Arizona
  • +71 more
Dec 9, 2022

Herpes Zoster Trial in Tartu (HZ/su vaccine)

Recruiting
  • Herpes Zoster
  • HZ/su vaccine
  • Elkridge, Maryland
  • +47 more
Jan 6, 2023

Advanced/Metastatic Solid Tumors Trial in Australia, China (ATG-022)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Adelaide, Australia
  • +3 more
Jan 30, 2023

Alpha 1-Antitrypsin Deficiency Trial in Gainesville, Charleston (ADVM-043)

Completed
Has Results
  • Alpha 1-Antitrypsin Deficiency
  • ADVM-043
  • Gainesville, Florida
  • +1 more
Aug 3, 2022

Systemic Lupus Erythematosus Trial in China (ICP-022, Placebos)

Completed
  • Systemic Lupus Erythematosus
  • Bengbu, Anhui, China
  • +10 more
Nov 28, 2022

Advanced/Metastatic Solid Tumors Trial in Frankston, Nedlands, Beijing (EMB07)

Not yet recruiting
  • Advanced/Metastatic Solid Tumors
  • Frankston, Victoria, Australia
  • +2 more
Nov 3, 2022

Mantle Cell Lymphoma Trial in China (ICP-022)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Hefei, Anhui, China
  • +30 more
Jul 5, 2022

Microcystic Lymphatic Malformation Trial in United States (PTX-022)

Recruiting
  • Microcystic Lymphatic Malformation
  • Little Rock, Arkansas
  • +5 more
Feb 25, 2022

CLL/SLL Trial in China (ICP-022)

Active, not recruiting
  • CLL/SLL
  • Hefei, Anhui, China
  • +24 more
Jul 5, 2022

Pachyonychia Congenita Trial in United States (PTX-022)

Active, not recruiting
  • Pachyonychia Congenita
  • Phoenix, Arizona
  • +3 more
Dec 2, 2021

Pachyonychia Congenita Trial in New Brighton (PTX-022)

Recruiting
  • Pachyonychia Congenita
  • New Brighton, Minnesota
    Minnesota Clinical Study Center
Dec 1, 2022

Migraine Trial in United States (AXS-07 (meloxicam-rizatriptan))

Recruiting
  • Migraine
  • AXS-07 (meloxicam-rizatriptan)
  • Colton, California
  • +18 more
Sep 19, 2022

Healthy, Bioequivalence Study Trial in Karachi (Dexlansoprazole)

Recruiting
  • Healthy
  • Bioequivalence Study
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research
Sep 5, 2022

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in China (ICP-022, Chlorambucil, Rituximab)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Bengbu, Anhui, China
  • +55 more
Mar 25, 2022

Peristomal Hernia Rate 5 Years AfterTerminal Colostomy With

Recruiting
  • Colostomy Stoma
  • Parastomal Hernia
    • Besançon, France
    • +15 more
    Sep 27, 2022

    Tumors, Metastatic Cancer, Advanced Cancer Trial in United States (Niraparib, TSR-042, Carboplatin-Paclitaxel)

    Active, not recruiting
    Has Results
    • Neoplasms
    • +6 more
    • Scottsdale, Arizona
    • +7 more
    Oct 31, 2022

    Melanoma Stage III, Melanoma Stage IV Trial in Washington, Boston, Pittsburgh (Dostarlimab (TSR-042) (singly), Dostarlimab

    Recruiting
    • Melanoma Stage III
    • Melanoma Stage IV
    • Dostarlimab (TSR-042) (singly)
    • Dostarlimab (TSR-042) and TSR-022 (combination)
    • Washington, District of Columbia
    • +2 more
    Feb 22, 2022

    KRAS G12V Mutant Advanced Epithelial Cancers Trial (Cyclophosphamide, Gemcitabine, Pembrolizumab)

    Available
    • KRAS G12V Mutant Advanced Epithelial Cancers
    • (no location specified)
    May 19, 2022

    Adult Primary Liver Cancer, Advanced Adult Primary Liver Cancer, Localized Unresectable Adult Primary Liver Cancer Trial in

    Recruiting
    • Adult Primary Liver Cancer
    • +2 more
    • TSR-022 and TSR-042
    • Honolulu, Hawaii
      University of Hawaii
    Sep 22, 2021